Melanocyte development and malignant melanoma.
Malignant melanoma is a notoriously aggressive disease that can affect relatively young individuals and whose incidence is rising at an alarming rate. Unlike many cancers, metastatic melanoma is poorly responsive to current therapies and mutations affecting p53, the retinoblastoma gene product or Ra...
Main Author: | |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|